• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精准医学公共卫生伦理的承诺:以新生儿预防性基因组测序为例。

The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing.

机构信息

Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Level 1 Medical Foundation Building, 92-94 Parramatta Road, Sydney, NSW, 2006, Australia.

出版信息

Hum Genet. 2022 May;141(5):1035-1043. doi: 10.1007/s00439-021-02269-0. Epub 2021 Mar 14.

DOI:10.1007/s00439-021-02269-0
PMID:33715055
Abstract

Precision medicine aims to tailor medical treatment to match individual characteristics and to stratify individuals to concentrate benefits and avoid harm. It has recently been joined by precision public health-the application of precision medicine at population scale to decrease morbidity and optimise population health. Newborn preventive genomic sequencing (NPGS) provides a helpful case study to consider how we should approach ethical questions in precision public health. In this paper, I use NPGS as a case in point to argue that both precision medicine and precision public health need public health ethics. I make this argument in two parts. First, I claim that discussions of ethics in precision medicine and NPGS tend to focus on predominantly individualistic concepts from medical ethics such as autonomy and empowerment. This highlights some deficiencies, including overlooking that choice is subject to constraints and that an individual's place in the world might impact their capacity to 'be responsible'. Second, I make the case for using a public health ethics approach when considering ethics and NPGS, and thus precision public health more broadly. I discuss how precision public health needs to be construed as a collective enterprise and not just as an aggregation of individual interests. I also show how analysing collective values and interests through concepts such as solidarity can enrich ethical discussion of NPGS and highlight previously overlooked issues. With this approach, bioethics can contribute to more just and more appropriate applications of precision medicine and precision public health, including NPGS.

摘要

精准医学旨在根据个体特征定制医疗方案,并对个体进行分层,以集中获益并避免伤害。最近,精准公共卫生也加入了进来——即在人群层面应用精准医学来降低发病率并优化人群健康。新生儿预防基因组测序(NPGS)为我们提供了一个很好的案例研究,以思考我们应该如何在精准公共卫生中处理伦理问题。在本文中,我以 NPGS 为例,认为精准医学和精准公共卫生都需要公共卫生伦理。我分两部分来论证这一观点。首先,我主张在精准医学和 NPGS 的伦理讨论中,往往倾向于关注来自医学伦理的主要是个人主义的概念,如自主性和赋权。这凸显了一些缺陷,包括忽略了选择受到限制,以及一个人在世界上的位置可能会影响他们“负责任”的能力。其次,我主张在考虑伦理和 NPGS 时,以及更广泛地考虑精准公共卫生时,采用公共卫生伦理方法。我讨论了精准公共卫生如何需要被理解为一个集体事业,而不仅仅是个体利益的集合。我还展示了如何通过团结等概念分析集体价值和利益,可以丰富对 NPGS 的伦理讨论,并突出以前被忽视的问题。通过这种方法,生物伦理学可以为更公正和更适当的应用精准医学和精准公共卫生,包括 NPGS,做出贡献。

相似文献

1
The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing.精准医学公共卫生伦理的承诺:以新生儿预防性基因组测序为例。
Hum Genet. 2022 May;141(5):1035-1043. doi: 10.1007/s00439-021-02269-0. Epub 2021 Mar 14.
2
Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine.成为合作伙伴,保持自主性:精准医学发展中的伦理考量
BMC Med Ethics. 2016 Nov 4;17(1):67. doi: 10.1186/s12910-016-0149-6.
3
Considering virtue: public health and clinical ethics.论美德:公共卫生与临床伦理。
J Eval Clin Pract. 2011 Oct;17(5):888-93. doi: 10.1111/j.1365-2753.2011.01721.x. Epub 2011 Aug 11.
4
Transparency, trust, and community welfare: towards a precision public health ethics framework for the genomics era.透明度、信任和社区福利:迈向基因组时代精准公共卫生伦理学框架。
Genome Med. 2020 Nov 20;12(1):98. doi: 10.1186/s13073-020-00800-y.
5
[Genomic newborn screening. Perspective from the Ethics Commission of the Spanish Society for Human Genetics. Part II: Ethical, legal and social issues (ELSIs) of the introduction of next generation sequencing technologies in a public health newborn screening program.].[基因组新生儿筛查。西班牙人类遗传学会伦理委员会的观点。第二部分:在公共卫生新生儿筛查项目中引入下一代测序技术的伦理、法律和社会问题(ELSI)。]
Rev Esp Salud Publica. 2022 Mar 14;96:e202203030.
6
A Bridge Back to the Future: Public Health Ethics, Bioethics, and Environmental Ethics.通向未来的桥梁:公共卫生伦理学、生命伦理学和环境伦理学。
Am J Bioeth. 2017 Sep;17(9):5-12. doi: 10.1080/15265161.2017.1353164.
7
Precision Medicine and Big Data: The Application of an Ethics Framework for Big Data in Health and Research.精准医学与大数据:大数据伦理框架在健康与研究中的应用
Asian Bioeth Rev. 2019 Sep 30;11(3):275-288. doi: 10.1007/s41649-019-00094-2. eCollection 2019 Sep.
8
Laying Anchor: Inserting Precision Health into a Public Health Genetics Policy Course.抛锚:将精准健康融入公共卫生遗传学政策课程
Healthcare (Basel). 2018 Aug 3;6(3):93. doi: 10.3390/healthcare6030093.
9
The Ethics of Tobacco Harm Reduction: An Analysis of E-Cigarette Availability From the Perspectives of Utilitarianism, Bioethics, and Public Health Ethics.烟草减害的伦理:从功利主义、生命伦理学和公共卫生伦理学的角度分析电子烟的可获得性。
Nicotine Tob Res. 2021 Jan 7;23(1):3-8. doi: 10.1093/ntr/ntaa198.
10
A Look at Uganda's Early HIV Prevention Strategies Through a Moderate 'African' Communitarian Lens.从适度的“非洲”社群主义视角审视乌干达早期的艾滋病病毒预防策略。
Dev World Bioeth. 2018 Jun;18(2):109-118. doi: 10.1111/dewb.12139. Epub 2016 Dec 28.

引用本文的文献

1
Guidance and Position of RINN22 regarding Precision Nutrition and Nutriomics.RINN22关于精准营养和营养组学的指南与立场。
Lifestyle Genom. 2025;18(1):1-19. doi: 10.1159/000542789. Epub 2024 Nov 30.
2
Genomic sequencing in newborn screening: balancing consent with the right of the asymptomatic at-risk child to be found.新生儿筛查中的基因组测序:平衡知情同意与发现无症状高危儿童的权利。
Eur J Hum Genet. 2025 Mar;33(2):182-188. doi: 10.1038/s41431-024-01677-w. Epub 2024 Aug 12.
3
'Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives.

本文引用的文献

1
Transparency, trust, and community welfare: towards a precision public health ethics framework for the genomics era.透明度、信任和社区福利:迈向基因组时代精准公共卫生伦理学框架。
Genome Med. 2020 Nov 20;12(1):98. doi: 10.1186/s13073-020-00800-y.
2
The role of exome sequencing in newborn screening for inborn errors of metabolism.外显子组测序在新生儿遗传代谢病筛查中的作用。
Nat Med. 2020 Sep;26(9):1392-1397. doi: 10.1038/s41591-020-0966-5. Epub 2020 Aug 10.
3
Impact of direct-to-consumer genetic testing on Australian clinical genetics services.
在基因组时代进行新生儿筛查时,将伦理学、公平性与经济学和有效性相结合:利益相关者观点的定性研究方案。
PLoS One. 2024 Mar 25;19(3):e0299336. doi: 10.1371/journal.pone.0299336. eCollection 2024.
4
Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?我们是否准备好对无症状新生儿进行全人群基因组测序?
Pharmgenomics Pers Med. 2023 Jul 1;16:681-691. doi: 10.2147/PGPM.S376083. eCollection 2023.
5
Storing paediatric genomic data for sequential interrogation across the lifespan.存储儿科基因组数据以便在整个生命周期进行连续询问。
J Med Ethics. 2025 Feb 21;51(3):205-211. doi: 10.1136/jme-2022-108471.
6
Communicating Personal Melanoma Polygenic Risk Information: Participants' Experiences of Genetic Counseling in a Community-Based Study.传达个人黑色素瘤多基因风险信息:基于社区研究中参与者的遗传咨询经历
J Pers Med. 2022 Sep 26;12(10):1581. doi: 10.3390/jpm12101581.
7
Newborn Screening by Genomic Sequencing: Opportunities and Challenges.通过基因组测序进行新生儿筛查:机遇与挑战
Int J Neonatal Screen. 2022 Jul 15;8(3):40. doi: 10.3390/ijns8030040.
8
The case for screening in early life for 'non-treatable' disorders: ethics, evidence and proportionality. A report from the Health Council of the Netherlands.早期生活中“不可治疗”障碍的筛查:伦理、证据和相称性。荷兰健康理事会报告。
Eur J Hum Genet. 2022 Oct;30(10):1155-1158. doi: 10.1038/s41431-022-01055-4. Epub 2022 Feb 7.
直接面向消费者的基因检测对澳大利亚临床遗传学服务的影响。
Eur J Med Genet. 2020 Sep;63(9):103968. doi: 10.1016/j.ejmg.2020.103968. Epub 2020 Jun 2.
4
Navigating conflicts of justice in the use of race and ethnicity in precision medicine.在精准医学中运用种族和族裔时应对正义冲突
Bioethics. 2020 Oct;34(8):849-856. doi: 10.1111/bioe.12757. Epub 2020 May 19.
5
Promises and perils of using genetic tests to predict risk of disease.使用基因检测预测疾病风险的前景与风险
BMJ. 2020 Feb 7;368:m14. doi: 10.1136/bmj.m14.
6
Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq.新生儿测序研究中的伦理问题:以 BabySeq 为例。
Pediatrics. 2019 Dec;144(6). doi: 10.1542/peds.2019-1031. Epub 2019 Nov 12.
7
Ensuring the Life-Span Benefits of Newborn Screening.确保新生儿筛查带来的终身益处。
Pediatrics. 2019 Dec;144(6). doi: 10.1542/peds.2019-0904. Epub 2019 Nov 6.
8
Rethinking the ethical principles of genomic medicine services.重新思考基因组医学服务的伦理原则。
Eur J Hum Genet. 2020 Feb;28(2):147-154. doi: 10.1038/s41431-019-0507-1. Epub 2019 Sep 18.
9
Reconceptualising precision public health.重新构想精准公共卫生。
BMJ Open. 2019 Sep 13;9(9):e030279. doi: 10.1136/bmjopen-2019-030279.
10
Validity of polygenic risk scores: are we measuring what we think we are?多基因风险评分的有效性:我们测量的是我们认为的吗?
Hum Mol Genet. 2019 Nov 21;28(R2):R143-R150. doi: 10.1093/hmg/ddz205.